miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1

被引:8
|
作者
Fan, Gentao [1 ]
He, Zhiwei [1 ]
Cao, Lili [1 ]
Shi, Xin [1 ]
Wu, Sujia [1 ]
Zhou, Guangxin [1 ]
机构
[1] Jinling Hosp, Dept Orthoped, Nanjing 210002, Jiangsu, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2019年 / 24卷
关键词
Osteosarcoma; miR-139; ROCK1; Proliferation; Invasion; EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; DOWN-REGULATION; MIGRATION; METASTASIS; APOPTOSIS; MICRORNAS; REGULATOR; GROWTH;
D O I
10.2741/4773
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
miR-139 has a tumor suppressor effect in many tumors. Here, we examined the suppressive role of this miRNA and its target, ROCK1, in osteosarcoma (OS), a highly malignant bone tumor that mainly affects children and adolescents. The expression of miR-139 was down-regulated in OS. Overexpression of miR-139 significantly inhibited OS cell proliferation, migration, and invasion. Ectopic expression of miR139 down-regulated ROCK1, a target of miR-139, by direct binding to its 3' untranslated region (3'UTR). Direct siRNA-mediated silencing of ROCK1 exerted an inhibitory effect on OS cell proliferation and invasion similar to the effect of miR-139. ROCK1 transfection reversed the suppressive effect of miR-139 on OS cell proliferation and invasion. Both miR-139 and siRNA knockdown of ROCK1 significantly downregulated beta-CATENIN and p-AKT and up-regulated E-CADHERIN and p53. The data provided here show that miR-139 exerts suppressive effects on proliferation and invasion of OS cells by targeting ROCK1.
引用
收藏
页码:1167 / 1177
页数:11
相关论文
共 50 条
  • [41] MiR-29c inhibits glioma cell proliferation, migration, invasion and angiogenesis
    Fan, Yue-chao
    Mei, Peng-jin
    Chen, Chen
    Miao, Fa-an
    Zhang, Hui
    Li, Zhong-lin
    JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (02) : 179 - 188
  • [42] MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1
    Zhu, Xiaoning
    Li, Wei
    Zhang, Renxian
    Liu, Yutao
    ONCOLOGY LETTERS, 2018, 16 (01) : 1298 - 1304
  • [43] Promotion of tumour proliferation, migration and invasion by miR-92b in targeting RECK in osteosarcoma
    Zhou, Zhenhua
    Wang, Zhiwei
    Wei, Haifeng
    Wu, Sujia
    Wang, Xudong
    Xiao, Jianru
    CLINICAL SCIENCE, 2016, 130 (11) : 921 - 930
  • [44] MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1
    Gong, Yubao
    Wei, Zheng-Ren
    BMC CANCER, 2022, 22 (01)
  • [45] MiR-155 inhibits proliferation, invasion and migration of melanoma via targeting CBL
    Li, H.
    Song, J-B.
    Chen, H-X.
    Wang, Q-Q.
    Meng, L-X.
    Li, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9525 - 9534
  • [46] miR-557 inhibits the proliferation and invasion of pancreatic cancer cells by targeting EGFR
    Yang, Yong
    Sun, Ke-Kang
    Shen, Xiao-Jun
    Wu, Xiao-Yang
    Li, De-Chun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (04): : 1333 - 1341
  • [47] Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1
    Lei Wang
    Yan Liu
    Zhengtao Yu
    Jianwu Gong
    Zhiyong Deng
    Nianjun Ren
    Zhe Zhong
    Hao Cai
    Zhi Tang
    Haofeng Cheng
    Shuai Chen
    Zhengwen He
    Journal of Translational Medicine, 19
  • [48] miR-494 inhibits cell proliferation and metastasis via targeting of CDK6 in osteosarcoma
    Yuan, Wei
    Wang, Du
    Liu, Yang
    Tian, Dongdong
    Wang, Yang
    Zhang, Ranxi
    Yin, Liangjun
    Deng, Zhongliang
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 8627 - 8634
  • [49] Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells
    Shang, Guanning
    Ma, Xu
    Lv, Gang
    CELL CYCLE, 2018, 17 (01) : 43 - 52
  • [50] MiR-139-5p Targeting CCNB1 Modulates Proliferation, Migration, Invasion and Cell Cycle in Lung Adenocarcinoma
    Bao, Bin
    Yu, Xiaojun
    Zheng, Wujun
    MOLECULAR BIOTECHNOLOGY, 2022, 64 (08) : 852 - 860